Form 4 Tracker
Aldeyra Therapeutics, Inc.
ALDX

11 insider filings · Latest: Jun 9, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 3, 2026Jun 5 8:19 PMTodd C BradyDirector, President and CEO
Purchase
250,000$1.67$418.4K1,721,298(D)

View →

Mar 19, 2026Mar 20 8:17 PMDOUGLAS RICHARDDirector
Purchase
70,000$1.40$98.0K195,000(D)

View →

Mar 18, 2026Mar 19 9:29 PMMichael AlfieriPrincipal Financial Officer
Purchase
5,000$1.42$7.1K7,500(D)

View →

Aug 12, 2025Aug 12 9:50 PMMachatha Stephen
Proposed Sale
22,074$5.26$116.1K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 9, 2026Jun 11 8:27 PMNancy Miller-RichDirector
Grant/Award
73,318$1.723,318(D)

View →

Jun 9, 2026Jun 11 8:26 PMDOUGLAS RICHARDDirector
Grant/Award
92,232$1.722,323(D)

View →

Jun 9, 2026Jun 11 8:25 PMGary M. PhillipsDirector
Grant/Award
81,613$1.724,977(D)

View →

Jun 9, 2026Jun 11 8:23 PMWilliam D ClarkDirector
Grant/Award
72,323$1.722,323(D)

View →

Jun 9, 2026Jun 11 8:21 PMNeal WalkerDirector
Grant/Award
73,318$1.723,318(D)

View →

Jun 9, 2026Jun 11 8:20 PMBen BronsteinDirector
Grant/Award
80,286$1.724,977(D)

View →

Jun 9, 2026Jun 11 8:18 PMDarlene M Deptula-HicksDirector
Grant/Award
94,313$1.729,756(D)

View →

Mar 27, 2026Mar 31 8:17 PMTodd C BradyDirector, President and CEO
Grant/Award
2,512,828$1.77632,318(D)

View →